Interactions between Xenobiotics and DME (XEOTIC)
|
Fungicide(s), Herbicide(s) or Insecticide(s) |
Fungicide |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Cyproconazole |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00942
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Fungicide |
DME Modulation |
Cyproconazole up-regulates the expression of DME CYP3A7 |
[1] |
Tebuconazole |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00957
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Fungicide |
DME Modulation |
Tebuconazole up-regulates the expression of DME CYP3A7 |
[2], [3] |
Herbicide |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
2,4,5-trichlorophenoxyacetic acid |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00966
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Herbicide |
DME Modulation |
2,4,5-trichlorophenoxyacetic acid induces the drug-metabolizing activity of DME CYP3A7 |
[4] |
Diuron |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00973
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Herbicide |
DME Modulation |
Diuron induces the drug-metabolizing activity of DME CYP3A7 |
[4] |
Pesticide/Insecticide |
Click to Show/Hide the Full List of Xenobiotics: 5 Xenobiotics
|
2,4-dichlorophenoxyacetic acid |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01609
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Pesticide/Insecticide |
DME Modulation |
2,4-dichlorophenoxyacetic acid induces the drug-metabolizing activity of DME CYP3A7 |
[4] |
Dicrotophos |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01050
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Pesticide/Insecticide |
DME Modulation |
Dicrotophos inhibits the expression of DME CYP3A7 |
[5] |
Imidacloprid |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01602
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Pesticide/Insecticide |
DME Modulation |
Imidacloprid induces the drug-metabolizing activity of DME CYP3A7 |
[6] |
Pentachlorophenol |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01605
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Pesticide/Insecticide |
DME Modulation |
Pentachlorophenol up-regulates the expression of DME CYP3A7 |
[7] |
Thiamethoxam |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01071
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Pesticide/Insecticide |
DME Modulation |
Thiamethoxam up-regulates the expression of DME CYP3A7 |
[8] |
Health or Environmental Toxicant(s) |
Acute Toxic Substance |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Fipronil |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01302
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Acute Toxic Substance |
DME Modulation |
Fipronil up-regulates the expression of DME CYP3A7 |
[9] |
Biotoxin |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Cylindrospermopsin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00905
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Cyanotoxin |
DME Modulation |
Cylindrospermopsin inhibits the expression of DME CYP3A7 |
[10] |
Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Benzo(a)pyrene |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00898
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen |
DME Modulation |
Benzo(a)pyrene up-regulates the expression of DME CYP3A7 |
[11], [12] |
Aflatoxin B1 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00806
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen-mycotoxin |
DME Modulation |
Aflatoxin B1 inhibits the expression of DME CYP3A7 |
[13] |
Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Tris(1,3-dichloro-2-propyl)phosphate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01031
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Health Hazard |
DME Modulation |
Tris(1,3-dichloro-2-propyl)phosphate up-regulates the expression of DME CYP3A7 |
[14] |
Natural Product(s), Extract(s) or Medicine(s) |
Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
4-oxoretinoic acid |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01154
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Product |
DME Modulation |
4-oxoretinoic acid inhibits the expression of DME CYP3A7 |
[15] |
Heliotrine |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01551
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Product |
DME Modulation |
Heliotrine inhibits the expression of DME CYP3A7 |
[16] |
Senecionine |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01585
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Natural Product |
DME Modulation |
Senecionine induces the drug-metabolizing activity of DME CYP3A7 |
[17] |
Plant Extract |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Plant extracts |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01574
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Plant Extract |
DME Modulation |
Plant extracts inhibits the expression of DME CYP3A7 |
[18] |
Pharmaceutical Agent(s) |
Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 19 Xenobiotics
|
Acetaminophen |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Acetaminophen inhibits the expression of DME CYP3A7 |
[19], [20] |
Alitretinoin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00167
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Alitretinoin inhibits the expression of DME CYP3A7 |
[15] |
Calcitriol |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00184
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Calcitriol up-regulates the expression of DME CYP3A7 |
[21], [22] |
Carbamazepine |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00011
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Carbamazepine up-regulates the expression of DME CYP3A7 |
[23] |
Clotrimazole |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00017
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Clotrimazole up-regulates the expression of DME CYP3A7 |
[24] |
Copper sulfate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00117
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Copper sulfate up-regulates the expression of DME CYP3A7 |
[25] |
Cyclosporine |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cyclosporine inhibits the expression of DME CYP3A7 |
[26] |
Dexamethasone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00088
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Dexamethasone up-regulates the expression of DME CYP3A7 |
[27], [28] |
Estradiol |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00090
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Estradiol inhibits the expression of DME CYP3A7 |
[29], [30] |
Fenofibrate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00035
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Fenofibrate up-regulates the expression of DME CYP3A7 |
[28] |
Isotretinoin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00186
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Isotretinoin inhibits the expression of DME CYP3A7 |
[15] |
Lindane |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00740
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Lindane induces the drug-metabolizing activity of DME CYP3A7 |
[4] |
Phenytoin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00232
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Phenytoin up-regulates the expression of DME CYP3A7 |
[31] |
Rifampin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00223
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Rifampin induces the drug-metabolizing activity of DME CYP3A7 |
[32] |
Tretinoin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00253
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Tretinoin inhibits the expression of DME CYP3A7 |
[33] |
Troglitazone |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00086
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Troglitazone inhibits the expression of DME CYP3A7 |
[34] |
Urethane |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00435
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Urethane inhibits the expression of DME CYP3A7 |
[14] |
Valproic acid |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00029
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Valproic acid inhibits the drug-metabolizing activity of DME CYP3A7 |
[35] |
Zoledronic acid |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00140
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Zoledronic acid up-regulates the expression of DME CYP3A7 |
[36] |
Drug in Phase 3 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
Diethyltoluamide |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00582
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 3 |
DME Modulation |
Diethyltoluamide up-regulates the expression of DME CYP3A7 |
[9] |
Seocalcitol |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00652
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 3 |
DME Modulation |
Seocalcitol up-regulates the expression of DME CYP3A7 |
[37] |
Vitamin E |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00547
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 3 |
DME Modulation |
Vitamin E inhibits the expression of DME CYP3A7 |
[38] |
Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
CI-1040 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00664
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
CI-1040 up-regulates the expression of DME CYP3A7 |
[39] |
Ethanol |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00539
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Ethanol inhibits the expression of DME CYP3A7 |
[40] |
PD-0325901 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00667
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
PD-0325901 up-regulates the expression of DME CYP3A7 |
[41] |
Drug in Phase 1 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Sodium arsenite |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00632
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
Sodium arsenite inhibits the expression of DME CYP3A7 |
[42] |
Investigative Agent |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Beta-naphthoflavone |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01220
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Investigative Agent |
DME Modulation |
Beta-naphthoflavone inhibits the expression of DME CYP3A7 |
[43] |
CITCO |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01165
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Investigative Agent |
DME Modulation |
CITCO induces the drug-metabolizing activity of DME CYP3A7 |
[44] |
|
|
|
|
|
|